ArticleEcancermedicalscience2013

Filgrastim XM02 (Tevagrastim®) after autologous stem cell transplantation compared to lenograstim: favourable cost-efficacy analysis.

A Gardellini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.